GSK Contests $5.2 Bil. Tax Bill After IRS Decision On Zantac Transfer Pricing
Executive Summary
GlaxoSmithKline and the Internal Revenue Service are headed to court over the IRS' conclusion that the company owes $5.2 bil. for unpaid taxes, penalty charges and interest